Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Celline
|
Drug
|
Regulatory
|
Score
|
Ref.
|
acc0801 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
H460 |
AZD6244 + BEZ235 |
Associated |
4.0 |
24939055
|
acc0802 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
H1975 |
AZD6244 + BEZ235 |
Associated |
4.0 |
24939055
|
acc0803 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
H1975 |
AZD6244 + BEZ235 |
Associated |
4.0 |
24939055
|
acc0804 |
HER2 |
phosphorylation |
Tyr1221 |
human |
Breast Cancer |
BT474c |
AZD5363 |
Impairing |
5.0 |
26095475
|
acc0805 |
HER2 |
phosphorylation |
Tyr1221 |
human |
Breast Cancer |
HCC1954 |
AZD5363 |
Impairing |
5.0 |
26095475
|
acc0806 |
HER2 |
phosphorylation |
Tyr1222 |
human |
Breast Cancer |
BT474c |
AZD5363 |
Impairing |
5.0 |
26095475
|
acc0807 |
HER2 |
phosphorylation |
Tyr1222 |
human |
Breast Cancer |
HCC1954 |
AZD5363 |
Impairing |
5.0 |
26095475
|
acc0808 |
HER3 |
phosphorylation |
Tyr1289 |
human |
Breast Cancer |
BT474c |
AZD5363 |
Impairing |
5.0 |
26095475
|
acc0809 |
HER3 |
phosphorylation |
Tyr1289 |
human |
Breast Cancer |
HCC1954 |
AZD5363 |
Impairing |
5.0 |
26095475
|
acc0810 |
RAF |
phosphorylation |
Ser338 |
human |
Glioblastoma |
U87 |
Berberine |
Associated |
4.0 |
25504754
|
acc0811 |
RAF |
phosphorylation |
Ser338 |
human |
Glioblastoma |
U251 |
Berberine |
Associated |
4.0 |
25504754
|
acc0812 |
ERK2 |
phosphorylation |
Thr185 |
human |
Glioblastoma |
U87 |
Berberine |
Associated |
4.0 |
25504754
|
acc0813 |
ERK2 |
phosphorylation |
Thr185 |
human |
Glioblastoma |
U251 |
Berberine |
Associated |
4.0 |
25504754
|
acc0814 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Glioblastoma |
U87 |
Berberine |
Associated |
4.0 |
25504754
|
acc0815 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Glioblastoma |
U251 |
Berberine |
Associated |
4.0 |
25504754
|
acc0816 |
MEK |
phosphorylation |
Ser217 |
human |
Glioblastoma |
U87 |
Berberine |
Associated |
4.0 |
25504754
|
acc0817 |
MEK |
phosphorylation |
Ser217 |
human |
Glioblastoma |
U251 |
Berberine |
Associated |
4.0 |
25504754
|
acc0818 |
MEK |
phosphorylation |
Ser221 |
human |
Glioblastoma |
U87 |
Berberine |
Associated |
4.0 |
25504754
|
acc0819 |
MEK |
phosphorylation |
Ser221 |
human |
Glioblastoma |
U251 |
Berberine |
Associated |
4.0 |
25504754
|
acc0820 |
ERK1 |
phosphorylation |
Thr202 |
human |
Glioblastoma |
U87 |
Berberine |
Associated |
4.0 |
25504754
|
acc0821 |
ERK1 |
phosphorylation |
Thr202 |
human |
Glioblastoma |
U251 |
Berberine |
Associated |
4.0 |
25504754
|
acc0822 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Glioblastoma |
U87 |
Berberine |
Associated |
4.0 |
25504754
|
acc0823 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Glioblastoma |
U251 |
Berberine |
Associated |
4.0 |
25504754
|
acc0824 |
Ezrin |
phosphorylation |
Thr567 |
human |
Nasopharyngeal Carcinoma |
5-8F |
Berberine |
Associated |
4.0 |
19651779
|
acc0825 |
AKT |
phosphorylation |
Ser473 |
human |
Melanoma |
A375 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0826 |
AKT |
phosphorylation |
Ser473 |
human |
Colorectal Cancer |
COLO205 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0827 |
S6 |
phosphorylation |
Thr389 |
human |
Colorectal Cancer |
COLO205 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0828 |
S6 |
phosphorylation |
Thr389 |
human |
Melanoma |
A375 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0829 |
AKT |
phosphorylation |
Ser473 |
human |
Melanoma |
A375 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0830 |
AKT |
phosphorylation |
Ser473 |
human |
Colorectal Cancer |
COLO205 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0831 |
ERK1 |
phosphorylation |
Thr202 |
human |
Melanoma |
A375 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0832 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Melanoma |
A375 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0833 |
ERK2 |
phosphorylation |
Thr185 |
human |
Melanoma |
A375 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0834 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Melanoma |
A375 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0835 |
ERK1 |
phosphorylation |
Thr202 |
human |
Colorectal Cancer |
COLO205 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0836 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Colorectal Cancer |
COLO205 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0837 |
ERK1 |
phosphorylation |
Thr202 |
human |
Melanoma |
A375 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0838 |
ERK2 |
phosphorylation |
Thr185 |
human |
Colorectal Cancer |
COLO205 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0839 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Colorectal Cancer |
COLO205 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0840 |
S6 |
phosphorylation |
Thr389 |
human |
Colorectal Cancer |
COLO205 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0841 |
S6 |
phosphorylation |
Thr389 |
human |
Melanoma |
A375 |
Dabrafenib |
Impairing |
5.0 |
29296217
|
acc0842 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Melanoma |
A375 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0843 |
ERK2 |
phosphorylation |
Thr185 |
human |
Melanoma |
A375 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0844 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Melanoma |
A375 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0845 |
ERK1 |
phosphorylation |
Thr202 |
human |
Colorectal Cancer |
COLO205 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0846 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Colorectal Cancer |
COLO205 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0847 |
ERK2 |
phosphorylation |
Thr185 |
human |
Colorectal Cancer |
COLO205 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0848 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Colorectal Cancer |
COLO205 |
Trametinib |
Impairing |
5.0 |
29296217
|
acc0849 |
Akt |
phosphorylation |
Ser473 |
rat |
Pituitary Tumor |
GH3 |
BKM120 |
Associated |
4.0 |
26983879
|
acc0850 |
Akt |
phosphorylation |
Ser473 |
rat |
Pituitary Tumor |
GH3 |
BEZ235 |
Associated |
4.0 |
26983879
|